InsiderSignal.AI

InsiderSignal.ai

ZIVO - Zivo Bioscience, Inc.

Insider Purchase by Strome Mark E (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Strome Mark E, serving as 10% owner at Zivo Bioscience, Inc. (ZIVO), purchased 20,000 shares at $9.77 per share, for a total transaction value of $195,400.00. Following this transaction, Strome Mark E now holds 472,942 shares of ZIVO.

This purchase represents a 4.00% increase in Strome Mark E's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 17, 2026, 5 days after the trade was made.

Zivo Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Strome Mark E

10%

Mark E. Strome is an American entrepreneur, investor, and philanthropist known for founding Strome Investment Management LP, Strome Group LP (2005), and Adesso Solutions LLC (2002), where he serves as chief investment officer and chairman.[[4]](https://en.wikipedia.org/wiki/Mark_Strome)[[7]](https://uk.marketscreener.com/business-leaders/Mark-E-Strome-05N956-E/biography/) He has incubated numerous public and private companies, including Pulse Biosystems (2017's most successful public offering), iWood Studios for film and TV content, and HyperXlogic, an advanced semiconductor design company focused on AI inference and national defense applications, where he is chairman and principal stockholder.[[4]](https://en.wikipedia.org/wiki/Mark_Strome) Strome is the sole director, president, and CEO of Strome Group, Inc.[[6]](https://ir.zivobioscience.com/all-sec-filings/content/0001174947-23-001251/ea187380-13da6strome_zivobio.htm?TB_iframe=true&height=auto&width=auto&preload=false) As a 10% owner of Zivo Bioscience, Inc. (ZIVO), Strome recently acquired 75,000 shares on December 26, 2024, for approximately $2 million, holding 398,683 shares valued at over $6 million as of mid-2025; related entities like Strome Mezzanine Fund, LP have also purchased shares.[[1]](https://www.gurufocus.com/insider/119054/mark-e-strome)[[5]](https://www.stocktitan.net/sec-filings/ZIVO/form-4-zivo-bioscience-inc-insider-trading-activity-f5ec23f3bff2.html) He holds similar 10% ownership stakes in The Arena Group Holdings Inc. (AREN) since 2018 and HeartBeam Inc. (BEAT) since 2023.[[1]](https://www.gurufocus.com/insider/119054/mark-e-strome)

View full insider profile →

Trade Price

$9.77

Quantity

20,000

Total Value

$195,400.00

Shares Owned

472,942

Trade Date

Thursday, February 12, 2026

10 days ago

SEC Filing Date

Tuesday, February 17, 2026

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Zivo Bioscience, Inc.

Company Overview

No company information available
View news mentioning ZIVO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4058251

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime